(redirected from Equine Protozoal Myeloencephalitis)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to Equine Protozoal Myeloencephalitis: equine protozoal myeloencephalitis (EPM)
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for equine

hoofed mammals having slender legs and a flat coat with a narrow mane along the back of the neck

References in periodicals archive ?
EBI's proprietary technology is a highly specific diagnostic test for equine protozoal myeloencephalitis (EPM), an emerging neurologic disease which causes economic loss to the horse industry.
IDEXX Pharmaceuticals also has a number of products in the registration process with the FDA, including a nitazoxanide-based product for treatment of equine protozoal myeloencephalitis -- a neurological disease that is believed to affect approximately 200,000 horses in the US; a topical non-steroidal anti-inflammatory for equine use; an insulin product for the treatment of diabetic cats; and a long-acting injectable antibiotic for cats are also in development.
Food and Drug Administration has informally told the Company that it is likely to issue an incomplete letter regarding the Company's new animal drug application (NADA) for nitazoxanide, a drug intended for the treatment of equine protozoal myeloencephalitis.
The Company is seeking FDA approval of a number of other drugs for companion animals, including a treatment for equine protozoal myeloencephalitis (EPM), a non-steroidal anti-inflammatory, and a novel, long-acting antibiotic for companion animals.
The new company is a leading-edge veterinary biotechnology company whose first product is the world's only reliable test for equine protozoal myeloencephalitis (EMP), which causes severe damage to horses' central nervous systems.
Full browser ?